𝔖 Bobbio Scriptorium

✦ LIBER ✦

Clinical outcomes of tigecycline alone or in combination with other antimicrobial agents for the treatment of patients with healthcare-associated multidrug-resistantAcinetobacter baumanniiinfections

✍ Scribed by Lee, Y.-T.; Tsao, S.-M.; Hsueh, P.-R.

Book ID: 120188935
Publisher: Springer
Year: 2013
Tongue: English
Weight: 193 KB
Volume: 32
Category: Article
ISSN: 0934-9723
DOI: 10.1007/s10096-013-1870-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Erratum to: Clinical outcomes of tigecyc

Erratum to: Clinical outcomes of tigecycline alone or in combination with other antimicrobial agents for the treatment of patients with healthcare-associated multidrug-resistantAcinetobacter baumanniiinfections

✍ Lee, Y.-T.; Tsao, S.-M.; Hsueh, P.-R. 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 52 KB

Open-Label Study of Pemetrexed Alone or

Open-Label Study of Pemetrexed Alone or in Combination with Cisplatin for the Treatment of Patients with Peritoneal Mesothelioma: Outcomes of an Expanded Access Program

✍ Pasi A. Jänne; Antoinette J. Wozniak; Chandra P. Belani; Mary-Louise Keohan; Hel 📂 Article 📅 2005 🏛 CIG Media Group, LP. 🌐 English ⚖ 512 KB

Intravitreal bevacizumab alone versus in

Intravitreal bevacizumab alone versus in combination with photodynamic therapy for the treatment of neovascular maculopathy in patients aged 50 years or older: 1-year results of a prospective clinical study

✍ Jong Yoon Lim; Sun Young Lee; June-Gone Kim; Joo Yong Lee; Hyewon Chung; Young H 📂 Article 📅 2010 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 315 KB

PDB17 Comparison of Clinical and Economi

PDB17 Comparison of Clinical and Economic Outcomes Associated With Dpp4 Inhibitors (DPP4I) Versus Sulfonylurea (SU) in Combination with Metformin (MET) or Pioglitazone (PIO) for the Treatment of Type 2 Diabetes Mellitus (T2DM)

✍ Bron, M.; Chen, K.; Cheng, D.; Bensimon, A.G.; Wu, E.Q. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

Durability of sustained virologic respon

Durability of sustained virologic response in patients with chronic hepatitis C after treatment with interferon α-2B alone or in combination with ribavirin: John G McHutchinson, Scripps Clinic, La Jolla, CA; Gary L Davis, University of Florida College of Medicine, Gainesville, FL; Rafael Esteban-Mur, Hospital Valle Hebrou, Barcelona Spain; Thierry Poynard, Hospitalier Pitie-Salpetriere, Paris France; Mei-Hsiu Ling, Jean-Jacques Garaud, Janice Albrecht For The International Hepatitis Interventional Therapy Group, Schering Plough Research Institute, Kenilworth, NJ

📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 198 KB